February 14, 2018 /
An
increase in multiple sclerosis cases in the Middle East and North
Africa has prompted Bayer to introduce to the region an injector that
patients can use to treat themselves.
increase in multiple sclerosis cases in the Middle East and North
Africa has prompted Bayer to introduce to the region an injector that
patients can use to treat themselves.
Researchers have suggested that increases in the region’s cases
stem from many people adopting Western lifestyles, including smoking and using
sun protection products, obtaining too little vitamin D, and being exposed to
environmental problems like air pollution.
stem from many people adopting Western lifestyles, including smoking and using
sun protection products, obtaining too little vitamin D, and being exposed to
environmental problems like air pollution.
Bayer said its auto-injector will be the first component of an
innovative dose delivery system for MS. Patients can use it by itself or as
part of a software-based system that keeps track of their injection history and
allows them to share information with healthcare providers.
innovative dose delivery system for MS. Patients can use it by itself or as
part of a software-based system that keeps track of their injection history and
allows them to share information with healthcare providers.
The U.S. Food and Drug Administration approved a supplemental
biologics license application in 2017 for two Bayer products designed
to help MS patients keep track of their injections of Betaseron
(interferon beta-1b. The approvals were for myBETAapp and Betaconnect
Navigator software.
biologics license application in 2017 for two Bayer products designed
to help MS patients keep track of their injections of Betaseron
(interferon beta-1b. The approvals were for myBETAapp and Betaconnect
Navigator software.
The navigator allows patients to use Bluetooth technology to
connect their autoinjector to a myBETAapp on their cellphone or laptop.
The connection lets them share their injection information with their
healthcare team. Patients can also manually enter injection information into
the myBETAapp.
connect their autoinjector to a myBETAapp on their cellphone or laptop.
The connection lets them share their injection information with their
healthcare team. Patients can also manually enter injection information into
the myBETAapp.
“Multiple Sclerosis is a rising concern across the
region,” Jihad Inshasi said in a news release that Bayer provided to
Multiple Sclerosis News Today. “It is a difficult condition to diagnose
due to the complexity and variability of symptoms, which may vary from one
person to the other.
region,” Jihad Inshasi said in a news release that Bayer provided to
Multiple Sclerosis News Today. “It is a difficult condition to diagnose
due to the complexity and variability of symptoms, which may vary from one
person to the other.
“Being diagnosed with multiple sclerosis is a critical life
event and can have a big impact on a patient’s life,” he said.
“However, with the new treatments in hand, patients can alleviate the
conditions that arise from the disease” and doctors can “improve the
quality of life of people living with this condition.”
event and can have a big impact on a patient’s life,” he said.
“However, with the new treatments in hand, patients can alleviate the
conditions that arise from the disease” and doctors can “improve the
quality of life of people living with this condition.”
Inshasi is a neurologist who directs the MS clinic at Rashid
Hospital in Dubai. He is also a member of the Middle East North Africa
Committee for Treatment and Research in Multiple Sclerosis.
Hospital in Dubai. He is also a member of the Middle East North Africa
Committee for Treatment and Research in Multiple Sclerosis.
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews
Stay informed with MS news and information - Sign-up here
For MS patients, caregivers or clinicians, Care to chat about MS? Join Our online COMMUNITY CHAT
